AbbVie Comprehensive Income 2010-2025 | ABBV

AbbVie comprehensive income for the quarter ending March 31, 2025 was $-1.742B, a 29.01% decline year-over-year.

  • AbbVie comprehensive income for 2024 was $-1.925B, a 16.49% decline from 2023.
  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.

AbbVie Comprehensive Income 2010-2025 | ABBV

  • AbbVie comprehensive income for 2024 was $-1.925B, a 16.49% decline from 2023.
  • AbbVie comprehensive income for 2023 was $-2.305B, a 4.82% increase from 2022.
  • AbbVie comprehensive income for 2022 was $-2.199B, a 24.15% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B